8 results
8-K
EX-99.1
OVID
Ovid Therapeutics Inc
19 Feb 19
Results of Operations and Financial Condition
4:01pm
: Summary Results from Four Phase 1 Trials in Healthy Volunteers Dosing (days) % of Baseline plasma 24HC conc. *One volunteer at 600mg QD experienced … acute psychosis; one volunteer at 300mg BID experienced an event of confusional state; one placebo volunteer reported events of nightmares, spatial
8-K
EX-99.1
OVID
Ovid Therapeutics Inc
7 Jan 19
Regulation FD Disclosure
6:31am
selection OV935: Summary Results from Four Phase 1 Trials in Healthy Volunteers Dosing (days) % of Baseline plasma 24HC conc. *One volunteer at 600mg QD … experienced acute psychosis; one volunteer at 300mg BID experienced an event of confusional state; one placebo volunteer reported events of nightmares
8-K
EX-99.2
6ab1a9fmkkgh azm7
17 Dec 18
Ovid Therapeutics Announces Phase 1b/2a Results of OV935/TAK-935 in Adults with Rare Epilepsies
8:05am
8-K
EX-99.1
xlt04lipwvx2yt
1 Oct 18
Regulation FD Disclosure
12:00am
10-K
ex9o2
29 Mar 18
Annual report
12:00am
- Prev
- 1
- Next